Hemodynamic phantom as a tool of research and development in the diagnosis of unstable ateroma
Public support
Provider
Ministry of Industry and Trade
Programme
—
Call for proposals
—
Main participants
PrimeCell Bioscience, a.s.
Contest type
OP - EU Operational Programme
Contract ID
MPO 56870/18/61200/3536
Alternative language
Project name in Czech
Hemodynamický fantom jako nástroj výzkumu a vývoje v diagnostice nestabilního ateromu
Annotation in Czech
Projekt je zaměřen na vývoj nových diagnostických metod pro detekci nestabilních arteriálních plátů a vývoj nástroje pro další vývoj diagnostické kontrastní látky detekující nestabilní pláty. Plánovanými hlavními výsledky projektu jsou dva prototypy - konkrétně pulzní perfuzní bioreaktor (vč. SW a HW) a simulátor oběhu (vč. SW a HW). Projekt bude realizován společností PrimeCell Bioscience, a.s. (střední podnik), v účinné spolupráci s organizací výzkumu a vývoje Univerzitou Palackého v Olomouci.
Scientific branches
R&D category
VV - Exeperimental development
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
FA - Cardiovascular diseases including cardio-surgery
CEP - another secondary branch
JC - Computer hardware and software
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20206 - Computer hardware and architecture<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30201 - Cardiac and Cardiovascular systems<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The developed hemodynamic phantom is immediately usable in clinical practice. As an innovative product, it is competitive and suitable for commercialization. It can also be used as an instructional model usable in teaching medical students.
Solution timeline
Realization period - beginning
Nov 30, 2017
Realization period - end
Aug 18, 2021
Project status
U - Finished project
Latest support payment
Feb 5, 2019
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP22-MPO-EG-U
Data delivery date
May 24, 2022
Finance
Total approved costs
7,345 thou. CZK
Public financial support
0 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
2,690 thou. CZK